Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Citi
Colorcon
Healthtrust
Chinese Patent Office

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,434,782

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,434,782
Title:Animal models and therapeutic molecules
Abstract: The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanized antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods.
Inventor(s): Bradley; Allan (Cambridge, GB), Lee; E-Chiang (Cambridge, GB), Liang; Qi (Cambridge, GB), Wang; Wei (Cambridge, GB), Friedrich; Glenn (Cambridge, GB)
Assignee: Kymab Limited (Cambridge, GB)
Application Number:14/137,902
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,434,782
Patent Claims:see list of patent claims

Details for Patent 9,434,782

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Kymab Limited (Cambridge, GB) 2029-07-08 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Kymab Limited (Cambridge, GB) 2029-07-08 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Kymab Limited (Cambridge, GB) 2029-07-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Harvard Business School
Mallinckrodt
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.